Basis: (FMP quote price / unrounded diluted TTM EPS) / five-year diluted EPS CAGR in percent, from annual statements through the period end shown. Source: stored company filings and market data; unavailable inputs remain N/A.
The PEG ratio is N/A as of 2026-10-06T14:22:24.806Z.
Calculation as of: 2026-10-06T14:22:24.806Z.
Quote observation: 2026-10-06T14:20:12.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 7de7752a9f7c92cf302168b3adc2b8952dbd3ee015c15fa7e623ade4200d4f53
PEG RATIO
N/A
| NAME | MARKET CAP | PEG RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Jade Biosciences, Inc. (JBIO) | $816.99M | N/A | N/A | N/A | N/A |
| Apnimed, Inc. (APMD)vs › | $818.83M | N/A | N/A | N/A | N/A |
| Alumis Inc. (ALMS)vs › | $825.62M | N/A | N/A | N/A | N/A |
| InMode Ltd. (INMD)vs › | $808.41M | 1.15 | 0.85 | 0.47 | 0.33 |
| Ardelyx, Inc. (ARDX)vs › | $809.02M | N/A | N/A | N/A | N/A |
| Beta Bionics, Inc. (BBNX)vs › | $835.01M | N/A | N/A | N/A | N/A |
| Gyre Therapeutics, Inc. (GYRE)vs › | $791.01M | N/A | N/A | N/A | N/A |
| Monte Rosa Therapeutics, Inc. (GLUE)vs › | $843.53M | N/A | N/A | N/A | N/A |
| AdaptHealth Corp. (AHCO)vs › | $793.88M | N/A | N/A | N/A | N/A |
| Mesa Laboratories, Inc. (MLAB)vs › | $770.19M | 12.06 | 8.33 | 8.33 | 8.33 |
PEG Ratio
N/A
P/E Ratio
N/A
PEG Ratio = P/E Ratio / 5-Year Diluted EPS CAGR (%)
The PEG ratio divides the price-to-earnings ratio by the company's five-year compound annual growth rate of diluted EPS, expressed in percent. A P/E of 20 and a five-year diluted EPS CAGR of 10% give a PEG of 2.0. The growth is reported, historical earnings growth from annual statements, not an analyst forecast. A PEG near 1 is often read as fairly priced for its growth; lower can mean cheaper relative to growth. The ratio is N/A when the P/E is unavailable or not positive, or when the five-year diluted EPS CAGR is unavailable or not positive. Each day of the history uses the CAGR that was known on that day.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute